Company / Named in our posts
Ikena Oncology, Inc..
Follow Ikena Oncology, Inc.A targeted oncology company focused on patient-directed cancer treatment.[1]
02Deals
Deals on Carrywatch
Every deal that names Ikena Oncology, Inc., and its role in each.
Ikena Oncology, Inc. / Inmagene Biopharmaceuticals
Ikena Oncology, Inc. completed its deal for Inmagene Biopharmaceuticals.
See deal detailsIkena Oncology, Inc. / Pionyr Immunotherapeutics, Inc.
Ikena Oncology, Inc. completes purchase of Pionyr Immunotherapeutics, Inc.
See deal detailsDeal Web
Ikena Oncology, Inc. and 1 firm it shares a posted deal with, and the path to any other firm.
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
- 02Form 8-K/A
U.S. Securities and Exchange Commission · Researched 24 Oct 2026
Deal posts naming Ikena Oncology, Inc.:
- P01
- P02